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Abstract
Cytomegalovirus (CMV) latent infection has a deleterious effect on the efficacy of influenza vaccination in the elderly,
suggesting that CMV restricts immunological diversity impairing the immune system functionality in old age. Polyfunctional
T cells produce multiple cytokines and higher amounts than mono-functional T cells. High number of polyfunctional T cells
correlates with better prognosis during infection. Thus, the efficiency of T cell response associates with quality
(polyfunctionality) rather than with quantity (percentage of T cells). We analyze the effect of CMV infection on CD8+ T cells
polyfunctionality ---degranulation (CD107a), IFN-gamma and TNF-alpha production---, from young CMV-seropositive and
CMV-seronegative individuals and in middle age CMV-seropositive donors, in response to Staphylococcal Enterotoxin B
mainly TNF-alpha or TNF-alpha/IFN-gamma producers, whereas the percentage of polyfunctional cells (IFN-gamma/TNF-
alpha/CD107a) is similar to the percentages found in young CMV-seropositive. Therefore, whereas it has been shown that
CMV latent infection can be detrimental for immune response in old individuals, our results indicate that CMV-seropositivity
is associated to higher levels of polyfunctional CD8+ T cells in young and middle age donors. This increase in
polyfunctionality, which can provide an immunological advantage in the response to other pathogens, is due to a
CD8+CD57+ T cell expansion in CMV-seropositive individuals and it is independent of age. Conversely, age could contribute
to the inflammation found in old individuals by increasing the percentage of cells producing pro-inflammatory cytokines.
These findings highlight the necessity of further studies on the benefits/detrimental effects of CMV infection in the response
to vaccination and other infections.
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Introduction
CMV chronic infection has a high prevalence that varies
worldwide. Seropositivity is related to geographic, ethnic and
social factors and increases with age [1]. In Spain up to 80% of
individuals over the age of 40 years are CMV-seropositive [2].
Primary CMV infection takes place generally during puberty, after
which the virus endures, controlled by constant surveillance of the
immune system [3,4]. In most cases, CMV infection is subclinical
and well tolerated, even though latent infection is associated with
an age-related deterioration of the immune system, in particular
CD8+ T cell compartment, causing a distortion of T cell
repertoire with expansions of CMV-specific CD8+ T cells that
can represent up to 20% of total CD8+ T cell population [5–7].
CMV-seropositivity is also associated with an increased risk of
death and cardiovascular diseases [8–10] and with the develop-
ment of an ‘‘Immune Risk Phenotype’’ (IRP), predictive of early
mortality in the elderly [11–13]. Thus, CMV is considered a major
driving force of immunosenescence characterized by the accumu-
lation of antigen-specific, oligoclonally expanded CD8+CD28–
CD57+ T cells. These cells have been proposed as terminally
differentiated, senescent, dysfunctional, effector-memory T lym-
phocytes that have gone through several rounds of cell divisions
(for review see [14,15]).
It has been suggested that the negative impact of CMV
seropositivity over survival in the elderly could be due, at least in
part, to the limitation in the T cell repertoire caused by the
expansion of dysfunctional and highly differentiated or senescent
CMV specific T cells, that affects the functional abilities of other T
cell populations combating new infections and/or tumors [16].
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(SEB). Our results show a higher percentage of polyfunctional CD8+ T cells in young CMV-seropositive individuals compared
to CMV-seronegative. Also, we find an expansion of CD8+CD57+ T cells in CMV-seropositive individuals, which are more
polyfunctional than CD8+CD57- cells.  In middle age individuals there is a higher frequency of SEB-responding CD8+ T cells,
It has been also shown that latent mouse CMV (MCMV)
infection impairs immunity to other viruses in old age and
increases the percentages and absolute numbers of CD8+ and
effector-memory CD8+ T cells, thus contributing to immunose-
nescence [17,18]. However, evidences from other studies in young
mice have shown that latent MCMV infection contributes to
immune protection against infection with unrelated pathogens
[19,20]. These apparently contradictory results make necessary to
analyze how CMV infection can affect the immune response in
young humans.
It is well known that a single T cell can produce simultaneously
multiple cytokines, being then commonly referred as polyfunc-
tional. Several publications have shown that a higher number of
polyfunctional T cells is correlated with a better prognosis during
HIV infection [21] and better response to vaccination in animals
[22], indicating that the efficiency of the response is associated
with the capacity of responding cells to produce several cytokines
(‘‘polyfunctionality’’ as a marker of quality) rather than with the
percentage (quantity) of specific T cells.
It has been shown that CMV-specific CD8+ T cells from elderly
donors retain their proliferative and cytotoxic capacity [23] and
that T cells responding to CMV are polyfunctional independently
of donor age [24]. Moreover, a recent study does not find
differences in the response to West Nile virus in a group of middle
age and aged individuals with large expansions of CMV-reactive
CD8+ T cells, indicating that CMV infection and the subsequent
expansion of CMV-specific CD8+ T cells do not limit the ability of
the host to respond to novel antigens [25].
However, whether CMV infection in young individuals affects
the polyfunctionality of CD8+ T lymphocytes in response to other
antigens has not yet been studied. The aim of this work is to
analyze the effect of CMV seropositivity and age on polyfunction-
ality of CD8+ T cells in response to the super-antigen
Staphyloccocal Enterotoxin B (SEB). To this end, we analyzed
CD8+ T cells polyfunctionality (degranulation, IFN-gamma and
TNF-alpha production) from young healthy individuals stratified
by CMV status and from middle age CMV-seropositive individ-
uals. The results obtained demonstrate that there is a higher
frequency of polyfunctional CD8+ T cells in response to SEB
stimulation in young and middle age CMV-seropositive donors,
compared with CMV-seronegative donors, which is associated to
the expansion of polyfunctional CD8+CD57+ T cells.
Results
Effect of age and CMV infection on CD8+ T cell response
to SEB stimulation
We analyzed IFN-gamma and TNF-alpha production as well as
the expression of CD107a, —a component of cytolytic granules,
which is used as a marker of CD8+ T cell degranulation after
activation— in CD8+ T cells from young CMV-seronegative
individuals, young CMV-seropositive and middle age individuals.
The percentage of CD8+ T cells was similar in the three groups
studied. The analysis of the frequency of SEB-responding CD8+ T
cells, considered as those capable of any kind of response
(CD107a, IFN-gamma, TNF-alpha), showed that the percentage
of SEB-responding CD8+ T cells is higher in middle age CMV-
seropositive individuals compared to young individuals, both
CMV-seropositive and CMV-seronegative. On the contrary, no
significant differences were observed between young CMV-
seronegative and CMV-seropositive individuals (Figure 1A).
When we analyzed each kind of response individually, we
observed that the percentage of IFN-gamma producing CD8+ T
cells was higher in young CMV-seropositive individuals compared
to young CMV-seronegative (Figure 1B). Middle age CMV-
seropositive individuals had a higher percentage of cytokine
producing CD8+ T cells (TNF-alpha or IFN-gamma) compared to
young donors (either CMV-seronegative or CMV-seropositive).
Besides, CD107a expression was higher in middle age CMV-
seropositive individuals when compared to young CMV-seroneg-
ative individuals.
Analysis of CD8+ T cells polyfunctionality was performed as
described in materials and methods (Figure S1). The percentage of
CD8+ T cells producing only IFN-gamma or IFN-gamma in
combination with CD107a (IFN-gamma/CD107a) in response to
SEB was noticeably low or null in all subjects studied,
independently of age or CMV-serostatus. In fact, CD8+ T cells
producing IFN-gamma were basically bi- or tri-functional (IFN-
gamma/TNF-alpha; CD107/IFN-gamma/TNF-alpha) in the
three groups studied (Figure 1C). Of notice is the increase of tri-
functional CD8+ T cells found in CMV-seropositive (young and
middle age) when compared to young CMV-seronegative
individuals. However, no significant differences were found in
the percentage of tri-functional CD8+ T cells between young and
middle age CMV-seropositive individuals, indicating that this
increase is associated mainly to CMV infection (Figure 1C). TNF-
alpha production was the single strongest response in the three
groups studied. The percentage of TNF-alpha producers within
CD8+ T cells (TNF-alpha and IFN-gamma/TNF-alpha produc-
ing cells) was significantly higher in middle age CMV-seropositive
individuals (Figure 1C).
Thus, CMV-seropositivity in young individuals is associated to
higher levels of polyfunctional CD8+ T cells that are maintained
in middle age. In addition, middle age donors have a higher
percentage of SEB-responding CD8+ T cells that are mainly TNF-
alpha single-producers or TNF-alpha and IFN-gamma double-
producers.
CD8+CD57+ T cells are more polyfunctional than
CD8+CD57– and are increased in CMV-seropositive
individuals
CD8+CD57+ T cell percentages were determined by gating on
resting CD3+ cells. The results showed a significant increase of
CD8+CD57+ T cell subset in young and middle age CMV-
seropositive individuals compared to young CMV-seronegative.
No significant differences on CD57 expression were observed
between resting and SEB stimulated CD8+ T cells (Figure 2A).
The analysis of the polyfunctional capacity of CD8+ T cells
responding to SEB in relation to CD57 expression in all
individuals showed a significant increase of tri-functional
CD8+CD57+ T cells and a lower frequency of single TNF-alpha
and double IFN-gamma/TNF-alpha producer CD8+CD57+ T
cells compared with CD8+CD57– T cells (Figure S2). These
differences between CD8+CD57+ and CD8+CD57– T cells were
also observed when donors were stratified according to CMV
serostatus (CMV-seronegative, CMV-seropositive) and/or age
(young, middle age) (Figure S3). In fact, CD8+CD57+ responding
T cells were mostly polyfunctional (CD107a/IFN-gamma/TNF-
alpha), while CD8+CD57– responding T cells were mainly mono-
functional (Figure 2B).
Analysis of CD8+CD57+ T cell functionality did not show
significant differences either with age or CMV seropositivity
(Figure 2B). Moreover, there was a significant correlation between
the percentage of CD8+CD57+ T cells and the percentage of tri-
functional CD8+ T cells (Figure 3), indicating that CMV
seropositivity increased CD8+ T cell polyfunctionality in young
individuals was due to the expansion of polyfunctional
CD8+CD57+ T cells in these individuals.
CMV and CD8+ T Cells Polyfunctionality
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When the functional capacity of CD8+CD57– T cells was
compared among the three groups studied, we observed a higher
percentage of TNF-alpha and IFN-gamma/TNF-alpha producing
cells in middle age CMV-seropositive individuals compared to
young donors (CMV-seropositive and CMV-seronegative). Thus,
the higher response of CD8+ T cells found in middle age CMV-
seropositive individuals when compared with young CMV-
seropositive individuals (Figure 1A, B) was due to a higher
percentage of non-cytotoxic (CD107a–) CD8+CD57- T cells that
responded to SEB by producing cytokines (TNF-alpha alone or
IFN-gamma/TNF-alpha) (Figures 2B, S2 and S3). It is of notice
that bi-functional IFN-gamma/TNF-alpha CD8+ T cells were
only found in the CD57- subset (Figure S2). With respect of CMV
seropositivity, there was a higher frequency of tri-functional
CD8+CD57– T cells in CMV-seropositive individuals (young and
middle age) compared with young CMV-seronegative (Figure 2B).
In summary, CMV seropositive donors have higher numbers of
polyfunctional CD8+ T cells associated to the expansion of
polyfunctional CD8+CD57+ T cells. Middle age individuals have
similar percentages of polyfunctional CD8+ T cells (both CD57-
and CD57+) and CD8+CD57+ T cells than young CMV-
seropositive donors. However, middle age CMV-seropositive
individuals have a higher frequency of CD8+CD57- T cells that
produce TNF-alpha alone or in combination with IFN-gamma.
Discussion
To the best of our knowledge, this is the first description that
young CMV-seropositive individuals have a higher percentage of
tri-functional CD8+ T cells in response to SEB, compared with
young CMV-seronegative individuals. This increase is associated
with the expansion of CD8+CD57+ T cells observed in CMV-
seropositive individuals that are mainly tri-functional and to some
extent to the higher levels of tri-functionality in the CD8+CD572
T cell subset. Furthermore the percentages of tri-functional CD8+
T cells and CD8+CD57+ T cells are similar among young and
middle age CMV2seropositive individuals. On the contrary, the
frequencies of CD8+CD572 T cells producing TNF-alpha or
IFN-gamma/TNF-alpha are significantly higher in middle age
compared with young CMV-seropositive donors.
Figure 1. CD8+ T cells’ responses to SEB stimulation, in healthy individuals stratified by CMV serostatus and age. A) Percentage of
CD3+CD8+ T cells that have any studied response to SEB. B) Total degranulation (CD107a) and cytokine production (IFN-gamma, TNF-alpha) by
CD3+CD8+ T lymphocytes responding to SEB. Vertical black lines indicate interquartile ranges, ranging from the 25th to the 75th percentile. The
median response for each category is indicated by a horizontal black line. C) Three-function analysis of SEB responses. Scatter graphs show the
magnitude of SEB responses in each functional category, expressed as percentage of CD3+CD8+ T cells. The combination of functions studied is
indicated in the table below the scatter graphs.
doi:10.1371/journal.pone.0088538.g001
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It has been demonstrated that protection against pathogens is
related to T cell quality (polyfunctionality) rather than to the
frequency of reactive T cells or the amount of the T cell response
[26,27]. Moreover, polyfunctional T cells produce higher amounts
of cytokines than mono-functional T cells, i.e., polyfunctional cells
are more efficient [24]. Thus our observation that young
CMV2seropositive subjects have an increased percentage of tri-
functional CD8+ T cells in response to SEB indicates that CMV
seropositivity improves the quality of the response to SEB. These
data support the possibility that CMV latency promotes the
response to non-related antigens through heterologous immunity.
Heterologous immunity refers to the protection that a host can
develop against one pathogen after being exposed to other non-
identical pathogens [28]. In particular, murine herpesviruses
provide heterologous immunity against other viruses and bacteria
and it has been suggested that herpesvirus latency has coevolved to
promote host immunity to infectious diseases [20]. Although most
studies on heterologous immunity have been performed in murine
models, there are evidences that it can also occur in human [28].
In particular it has been shown that CMV infection enhances the
immune response against measles vaccination in Gambian infants
[29].
Our results show a CD8+CD57+ T cell expansion in CMV-
seropositive individuals (young and middle age) compared to
young CMV-seronegative. The expansion of CD8+CD57+ T cells
has been described in different conditions associated to chronic
immune stimulation such as virus infections, transplantation,
autoimmune diseases and ageing (for review see [25,30,31]). The
expansion of CD57+ cells in these clinical conditions has been
associated with lower expression of CD28 and replicative
senescence with a decreased proliferative capacity [32,33].
However, there is evidence that CD8+CD57+ T cells proliferate
under certain conditions [34]. In addition, it has been shown that
these cells are mainly cytotoxic and produce IFN-gamma [35,36].
In our hands, CD8+CD57+ T cells are mostly tri-functional and
the higher frequency of SEB-responding polyfunctional CD8+ T
cells found in CMV-seropositive individuals is mainly due to the
expansion of these CD8+CD57+ T cells.
CD8+CD57+ T cells (or CD8+CD282 T cells) expand with
ageing [30,31]. Considering that the frequency of CMV-seropos-
Figure 2. CD8+CD57+ T cell frequency and functionality in healthy individuals. A) CD57 expression in CD8+ T cells of healthy individuals
stratified by CMV serostatus and age. B) Three-function analysis of SEB responses of CD8+CD57– and CD8+CD57+ T cell subsets. Scatter graphs show
the magnitude of SEB responses in each functional category, expressed as percentage of CD8+CD57- T cells or CD8+CD57+ T cells. Vertical black lines
indicate interquartile ranges, ranging from the 25th to the 75th percentile. The median response for each category is indicated by a horizontal black
line. The combination of functions studied is indicated in the table below the scatter graphs.
doi:10.1371/journal.pone.0088538.g002
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itive individuals increases with age in different social and ethnic
groups [1], our results support the possibility that the major factor
involved in this expansion is CMV latent infection rather than
ageing. In addition it has been reported the expansion of these
cells in several clinical situations characterized by chronic
activation of the immune system [30,37]. However, CMV
seropositivity has not been analyzed in the majority of these
studies, so the possible involvement of CMV in the increased
percentage of CD8+CD57+ T cells cannot be excluded.
IFN-gamma production by CD8+CD57+ T cells has been
suggested to play a detrimental role contributing to age-associated
inflammatory diseases [38]. However, since our data show that
IFN-gamma production by CD8+CD57+ T cells is a marker of
CD8+ T cell polyfunctionality, it should be considered that
CD8+CD57+ T cells play a beneficial role in the immune response
against pathogens. On the contrary we have observed a higher
percentage of CD8+CD572 T cells producing TNF-alpha alone
or TNF-alpha and IFN-gamma in middle age individuals.
Considering the relevance of TNF-alpha not only in inflammation
but also in superantigen-induced toxic shock, we suggest that this
cytokine pattern in CMV-seropositive individuals might be
involved in age-associated inflammatory diseases. In addition,
the higher levels of cytokines, in particular TNF-alpha, produced
in response to SEB in CMV-seropositive individuals might
contribute to toxic shock induced by bacterial superantigens.
It has been proposed that CMV is a major driving force of
human T cell immunosenescence [5,37,39,40]. It is well estab-
lished that CMV infection has a deleterious effect on the efficacy of
influenza vaccination both in young and elderly individuals [41],
suggesting that CMV chronic infection restricts immunological
diversity and impairs the immune system functionality. However,
a recent study does not find differences in the response to West
Nile virus in a group of middle age and aged individuals with large
expansions of CMV-reactive CD8+ T cells, indicating that CMV
infection does not limit the ability of the host to respond to novel
antigens [25].
In summary our results showing that CMV infection is
associated to a higher frequency of polyfunctional CD8+CD57+
T cells support the hypothesis that herpesvirus latency contributes
to protection against some pathogens [19,20]. As pointed out by
Unanue [42] throughout evolution, latent herpesvirus infection
could provide an immunological advantage, by keeping the
immune system in a state of alert, which could explain the high
prevalence of these viruses, in particular CMV, in humans. Thus
in developing countries the cross-protection provided by CMV
could be important to overcome other viral and bacterial
infections in early years. However, surviving to infections in the
infancy is not now a major issue in developed countries, whereas a
lifelong activated immune system can trigger aberrant immune
inflammatory responses that could lead to age-associated diseases.
Therefore, the balance between the possible positive and negative
effects of CMV should be considered in CMV vaccine studies.
These facts raise the issue of the possible benefit or detriment from
CMV eradication. Our results highlight the requirement of further
studies to analyze how CMV latent infection affects the immune
response to vaccination and to other infections in all groups of age,
not only in the elderly but also in the infancy and in the young, in
different socio-economic population groups.
Materials and Methods
Ethics statement
The study was approved by the Ethics Committee of the Reina
Sofia University Hospital. All study participants provided
informed written consent.
Subjects
We studied 32 healthy donors; 20 young individuals (18–35
years old) stratified by CMV serostatus –10 CMV-seronegative (4
male/6 female; mean age 26.3, SD = 5.8) and 10 CMV-
seropositive (6 male/4 female; mean age 27, SD = 4.3) – and 12
middle age individuals all of them CMV-seropositive (3 male/9
female; 40–60 years old, mean age 50.25, SD = 4.3). Due to the
high prevalence of CMV in Spain we could not recruit enough
middle age CMV-seronegative individuals (over 80% in older than
40 years old [2]). All subjects studied met the following exclusion
criteria: absence of diabetes, cancer, severe renal failure, severe
liver disease, endocrine disorders, autoimmune diseases, or acute
infectious disease; they were not consuming drugs whose activity is
known to modify the functions of the immune system.
Peripheral blood from each subject was collected by venipunc-
ture in Lithium Heparin-containing tubes. Within 1–3 h after
collection PBMCs were isolated from each blood sample using
Ficoll-Histopaque density gradient centrifugation (Sigma Aldrich.
Steinheim, Germany) and cryopreserved until the time the
experiments were performed.
CMV serology
Plasma or sera from all donors were tested for CMV-specific
IgG and IgM by automated CMV enzyme-linked immunosorbent
assay (ELISA), (Genesis Diagnostics, Cambridge, UK).
Stimulation, intracellular staining, and detection of
CD107a expression
As CD107a expression has been directly correlated with CD8+
T cell cytotoxicity [43,44], we used this marker for the
degranulation assays.
Figure 3. Correlation between tri-functional CD8+ T cells and
CD57 expression in the individuals studied (n=32). Y axis
represents the percentage of CD8+ T cells that express CD57. X axis
represents the percentage of tri-functional CD8+ T cells.
doi:10.1371/journal.pone.0088538.g003
CMV and CD8+ T Cells Polyfunctionality
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Freshly thawed, cryopreserved PBMCs were resuspended at
16106 cells/ml in complete RPMI media (RPMI 1640 supple-
mented with 10% heat inactivated FCS, 100 U/ml penicillin G,
100 mg/ml streptomycin sulphate and 17 mM sodium glutamate)
and rested overnight at 37uC in a standard incubator (humidified
CO2 atmosphere).
The following day, cells were placed in a 96 well plate at
26106 cells/ml concentration (250 ml final volume). Costimula-
tory antibodies (anti-CD28 and anti-CD49d; 1 mg/ml each; BD
Biosciences) and anti-CD107a-APC (BD Biosciences) were added
to all wells. Staphylococcal Enterotoxin B superantigen (SEB,
Sigma-Aldrich) was added at a final concentration of 1 mg/ml. For
each individual a negative control, containing only anti-CD28 and
anti-CD49d, was included to measure antigen-independent
stimulation.
The plate was placed in a standard incubator (37uC, humidified
CO2 atmosphere) and, after 1 h, each well received the addition of
monensin (Golgistop, 0.67 ml/ml; BD Biosciences) and brefeldin A
(Golgi Plug 1 mg/ml; BD Biosciences). Cells were then incubated
for an additional 4 h. Following incubation, cells were washed
twice with PBS (4uC) and stained with surface antibody (CD57-
VioBlue, Miltenyi Biotec). Cells were then fixed and permeabilized
with Cytofix/Cytoperm solution according to the manufacturer’s
instructions (BD PharMingen) and subsequently stained intracel-
lularly with CD3-PerCP, CD8-APC-Cy7 (BD Biosciences), IFN-
gamma-FITC and TNF-alpha-PE (Miltenyi Biotec) antibodies,
since it is preferable to stain cells with anti-CD3 and anti-CD8
antibodies after they are permeabilized, to partially, if not fully,
eliminate the reduced staining of these molecules on the cell
surface of activated T cells due to surface down-modulation of
these markers after activation [43]. For isotype controls we
followed the same protocol as samples. All antibodies used in the
experiment were titrated before use. Stained cells were analyzed
by flow cytometry the following day.
Flow cytometry and data analysis
Flow cytometric analysis was performed on a two-laser
MACsQuant instrument (Miltenyi Biotech) using MACSQuantify
software. For each sample, data from almost 40.000 events of
CD3+CD8+ gate were collected. Files were gated on small
lymphocytes (using forward vs side scatter). When indicated the
expression of CD57 was analyzed on resting CD8+ T cells.
Degranulating and cytokine-producing populations were de-
fined as the percentage of the CD107a, IFN-gamma or TNF-
alpha events gated on CD3+CD8+ T cells. The gating strategy
used for polyfunctionality (CD107a, IFN-gamma, TNF-alpha)
measurements is illustrated in Figure S1.
To study polyfunctionality of CD57 expressing CD8+ T cells
after SEB stimulation, CD3+CD8+ T lymphocytes were gated and
then divided into four quadrants: CD57-CD1072,
CD572CD107+, CD57+CD1072, CD57+CD107+. Cytokine
production of IFN-gamma and/or TNF-alpha was defined by
gating on each of these four CD8+ T cells subsets. The settings for
CD107a, IFN-gamma and TNF-alpha staining were defined on
the basis of an isotype-matched negative control of irrelevant
specificity in separate unstimulated culture.
Statistical analysis
Net responses were calculated by subtracting values for the
negative control from SEB responses. For direct comparison of
three independent samples, Kruskal-Wallis H test (nonparametric
test) was used. Mann-Whitney U nonparametric test was used to
derive p values for comparing data among the specific sample
pairs. For comparison between CD8+ T cells responses to SEB
and CD57 expression in CD8+ T cells Spearman correlation test
was used. All statistical tests were performed with PASW Statistics
v18; p values #0.05 were considered significant.
Supporting Information
Figure S1 Flow cytometry gating strategy used in the
analysis of polyfunctionality flow cytometry data. Figure
shows PBMCs of a CMV-seropositive young healthy individual,
stimulated with SEB. After initial gating on lymphocytes, cells
were then selected based on CD3+CD8+ staining and then
divided into two gates CD107- and CD107+. Each gate was then
analyzed into a four quadrant plot representing IFN-gamma and/
or TNF-alpha responses (IFNg-TNFa-, IFNg+TNFa-, IFNg-
TNFa+, IFNg+TNFa+). Values are referred to the total of
CD8+ T cells.
(TIF)
Figure S2 CD8+ T cell polyfunctionality in relation to
CD57 expression. Polyfunctionality flow cytometry analysis of
CD8+CD57– and CD8+CD57+ T cell subsets, in response to SEB
stimulation. This figure summarizes data for all 32 healthy
individuals enrolled in this study. Scatter graphs show the
magnitude of SEB responses in each functional category,
expressed as percentage of CD8+CD572 T cells or CD8+CD57+
T cells. Vertical black lines indicate interquartile ranges, ranging
from the 25th to the 75th percentile. The median response for
each category is indicated by a horizontal black line. The
combination of functions studied is indicated in the table below
the scatter graphs. Panel A, cells responding to SEB stimulation.
Panel B cells that do not respond to SEB stimulation.
(TIF)
Figure S3 CD8+ T cell polyfunctionality, in relation to
CD57 expression, in the different groups. Each graph
shows the polyfunctional responses to SEB of CD8+CD57– and
CD8+CD57+ T cell subsets for each group studied (young CMV-
seronegative, young CMV-seropositive and middle age CMV-
seropositive). Scatter graphs show the magnitude of SEB responses
in each functional category, expressed as percentage of
CD8+CD572 T cells or CD8+CD57+ T cells. Vertical black
lines indicate interquartile ranges, ranging from the 25th to the
75th percentile. The median response for each category is
indicated by a horizontal black line. The combination of functions
studied is indicated in the table below the scatter graphs.
(TIF)
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